EASY BIO,Inc. (KOSDAQ: 353810)
South Korea
· Delayed Price · Currency is KRW 3,600.00
+210.00 (6.19%)
Nov 15, 2024, 9:00 AM KST
EASY BIO,Inc. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 17,336 | 15,544 | 9,131 | 10,873 |
| Depreciation & Amortization | 4,298 | 3,692 | 3,763 | 2,801 |
| Loss (Gain) From Sale of Assets | -6.01 | 7.04 | 0.33 | -0.9 |
| Loss (Gain) From Sale of Investments | -2,041 | -1,118 | - | - |
| Loss (Gain) on Equity Investments | -836.55 | -1,106 | -592.15 | -12.04 |
| Provision & Write-off of Bad Debts | 38.31 | -524.94 | 278.77 | 193.34 |
| Other Operating Activities | 3,018 | 1,958 | 1,455 | 281.15 |
| Change in Accounts Receivable | -514.19 | -82.57 | -5,615 | 5,601 |
| Change in Inventory | 6,260 | 3,031 | -4,871 | -2,207 |
| Change in Accounts Payable | 715.68 | -23.51 | 1,907 | -1,845 |
| Change in Other Net Operating Assets | 3,989 | 12,307 | -13,580 | -1,618 |
| Operating Cash Flow | 32,258 | 33,684 | -8,124 | 14,066 |
| Capital Expenditures | -4,480 | -1,886 | -1,954 | -1,834 |
| Sale of Property, Plant & Equipment | 441.64 | 10.31 | 2.27 | 8.8 |
| Cash Acquisitions | -87,933 | - | - | -8,876 |
| Sale (Purchase) of Intangibles | -55.8 | -78.45 | -94.69 | -4.53 |
| Investment in Securities | -48,514 | -39,386 | 2,561 | -9,354 |
| Other Investing Activities | 0 | 0 | -0 | -0 |
| Investing Cash Flow | -140,541 | -41,340 | 513.77 | -20,060 |
| Short-Term Debt Issued | - | 120,996 | 76,277 | 43,778 |
| Long-Term Debt Issued | - | 20,000 | 15,000 | 2,500 |
| Total Debt Issued | 227,858 | 140,996 | 91,277 | 46,278 |
| Short-Term Debt Repaid | - | -136,441 | -44,695 | -34,394 |
| Long-Term Debt Repaid | - | -5,336 | -16,143 | -3,094 |
| Total Debt Repaid | -103,279 | -141,778 | -60,838 | -37,488 |
| Net Debt Issued (Repaid) | 124,578 | -782.09 | 30,438 | 8,790 |
| Dividends Paid | -3,479 | -2,626 | -2,560 | -2,560 |
| Other Financing Activities | 664.65 | -0 | - | -0 |
| Financing Cash Flow | 121,764 | -3,408 | 27,878 | 6,229 |
| Foreign Exchange Rate Adjustments | 320.19 | 220.04 | -1,059 | 20.38 |
| Miscellaneous Cash Flow Adjustments | 0 | - | -0 | 0 |
| Net Cash Flow | 13,801 | -10,844 | 19,209 | 255.31 |
| Free Cash Flow | 27,778 | 31,798 | -10,079 | 12,231 |
| Free Cash Flow Margin | 11.31% | 19.23% | -6.48% | 9.45% |
| Free Cash Flow Per Share | 813.79 | 931.49 | -295.24 | 358.86 |
| Cash Interest Paid | 2,742 | 2,893 | 1,391 | 1,210 |
| Cash Income Tax Paid | 6,444 | 2,999 | 3,396 | 3,396 |
| Levered Free Cash Flow | -30,438 | -10,238 | -9,100 | - |
| Unlevered Free Cash Flow | -27,048 | -8,226 | -8,024 | - |
| Change in Net Working Capital | 42,724 | 22,848 | 19,835 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.